Position in NBIX
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$240,169
-$13,167 QoQ
Shares Held
1,425
-25.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#571
of 768 holders
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Claret Asset Management Corp holds $30,317,140 across 7 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
685,523 | $28,127,008 | |
| 2 | BHC |
Bausch Health Companies Inc.
|
204,108 | $1,006,252 | |
| 3 | ZTS |
Zoetis Inc.
|
3,526 | $253,378 | |
| 4 | VTRS |
Viatris Inc
|
15,214 | $241,598 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
1,425 | $240,169 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
9,119 | $224,418 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
414 | $224,317 |
All Filings in NBIX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $240,169 | 1,425 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $253,336 | 1,923 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $273,873 | 1,931 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $256,614 | 1,828 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $233,029 | 1,854 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $203,931 | 1,494 | Shares | Sole | 2025-02-13 | |
| 2024-03-31 | $200,121 | 1,451 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $206,204 | 1,565 | Shares | Sole | 2024-02-12 | |
| No filing history on record for this holder in this stock. | ||||||